Genes & biomarkers

PDGFRA variants

PDGFRA · exon 18 / D842V

In GIST, the exact variant, such as D842V, matters for drug selection.

Sources checked · Introductory guide

On this page

What does this result mean?

PDGFRA encodes a growth-signaling receptor. Point variants in some GIST differ from PDGFRA fusions found in certain blood disorders.[1]

How does it connect to treatment?

In the US, avapritinib is approved for adults with unresectable/metastatic GIST carrying PDGFRA exon 18 variants, including D842V. Not every PDGFRA alteration qualifies for the same drug.[2]

What should I check in my report?

Check D842V status, exon number and whether the finding is a point variant or fusion. The same gene name in another GIST patient does not establish the same drug choice.

Questions for your care team

  • Does my PDGFRA result show D842V or another exon 18 variant?
  • Which treatments or trials fit my cancer type, stage and previous treatment?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. MedlinePlus Genetics · PDGFRA (opens in a new tab)
  2. NCI · Avapritinib for GIST with PDGFRA alteration (opens in a new tab)
  3. NCI · Avapritinib (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

PDGFRA variants | Cancer Encyclopedia | My Chemo Diary